Back to News
Market Impact: 0.18
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationCompany Fundamentals
Investor-rights law firm Bronstein, Gewirtz & Grossman announced that a class action lawsuit has been filed against Regeneron Pharmaceuticals (REGN) and certain officers. The filing itself is not quantified, but it introduces potential legal overhang and liability risk that could weigh modestly on sentiment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
REGN-0.85
More News
- Chinese Nvidia rival Enflame soars 206% on stock market debut as AI demand stays hot
- Microsoft AI Focused Data Center Plan to Add 26 Gigawatts of Compute
- Jensen Huang explains why Nvidia will grow an astounding 70% next year
- Oracle's stock jumps 7% on earnings beat as cloud infrastructure revenue more than doubles
- Kaplan Fox Reminds Investors of DICK s Sporting Goods, Inc. (NYSE: DKS) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026
- Kaplan Fox Announces a Securities Class Action Filed Against Hims & Hers Health, Inc. (NYSE: HIMS) - Lead Plaintiff Deadline is November 2, 2026